Close Menu

NEW YORK (GenomeWeb) – Genomic services contract research organization Genewiz and Hy Laboratories today announced a partnership to develop diagnostic panels to characterize the gut microbiome in patients with obesity and diabetes.

The multiyear project seeks to stratify patients with diabetes and obesity for bariatric surgery or alternative treatments. Obesity and diabetes are closely related to the function and population of the gut microbiome, the firms said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.